Maple Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Maple Capital Management's IDXX Position: Q3 2026 in Review
Maple Capital Management reduced its Idexx Laboratories (IDXX) stake by 0.85% in Q3 2026, selling an estimated $2.19K and leaving 465 shares worth $243K. The position accounts for 0.01% of the portfolio, ranked #108.
Maple Capital Management first reported a position in IDXX in Q2 2019 and has held it in 27 quarters since. The position peaked at $447K in Q2 2021. 682 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- Maple Capital Management held 465 shares of Idexx Laboratories worth $243K as of Q3 2026.
- Maple Capital Management sold 4 Idexx Laboratories shares in Q3 2026, an estimated $2.19K.
- Idexx Laboratories made up 0.01% of Maple Capital Management's portfolio in Q3 2026, its #108 holding.
- Maple Capital Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 27 quarters since.
- Maple Capital Management's Idexx Laboratories position peaked at $447K in Q2 2021.
- 682 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on Maple Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.